27 results
8-K
EX-2.1
ALKS
Alkermes plc
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
) in the reasonable judgment of the Indemnitee, after consultation with outside counsel, there exists a conflict of interest between the Indemnifying Party
DEFA14A
ALKS
Alkermes plc
21 Jun 23
Additional proxy soliciting materials
8:06am
a close personal partner of Dr. Denner on Biogen’s board truly resolves the Company’s stated concerns regarding a potential conflict of interest.”
“[T]he
DEFA14A
ALKS
Alkermes plc
20 Jun 23
Additional proxy soliciting materials
7:11am
resignation may have been to avoid the conflict of interest that could result from the contentious commercial relationship between Biogen and Alkermes … . Unfortunately, Denner’s decision to replace himself with a close affiliate does little to mitigate the potential conflict of interest. Further, this approach
DEFA14A
oslor 8pnup
8 Jun 23
Additional proxy soliciting materials
7:30am
DEFA14A
0c4dvdd92 9nq2vr
7 Jun 23
Additional proxy soliciting materials
5:28pm
DFAN14A
zdl6tsw 44eo
6 Jun 23
Additional proxy materials by non-management
5:21pm
DEFC14A
ruyg6sdu1
25 May 23
Proxy in contested solicitation
4:03pm
PRER14A
pewbpgf89zgq0h ux
19 May 23
Preliminary revised proxy
5:23pm
PREC14A
d5l 9drthnesjxrpc08
8 May 23
Preliminary proxy with contested solicitation
4:34pm
DEFC14A
o7h7vs3gl3ez
6 Jun 22
Proxy in contested solicitation
5:29pm
PREC14A
4vrpvy57wzq 8wrc43
26 May 22
Preliminary proxy with contested solicitation
5:29pm